CytaCoat €50k

Case

CytaCoat has developed a unique and stable antimicrobial coating that uses non-toxic, biocompatible organic compounds that strongly bind to the surface of the device through covalent bonding. Cytacoat has been granted EUR 50k from SME Instrument Phase 1. GAEU helped structuring the project and highlight the parts essential in order for the commission to see the potential of the project, even though it was at a very early stage in its development, and very venturous.